tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Protara Therapeutics: Buy Rating Backed by Promising Clinical Advancements and Strategic Focus on Unmet Medical Needs
PremiumRatingsProtara Therapeutics: Buy Rating Backed by Promising Clinical Advancements and Strategic Focus on Unmet Medical Needs
1M ago
Protara Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Protara Therapeutics Reports Q2 2025 Financial Results
1M ago
Protara Therapeutics reports Q2 EPS (35c), consensus (38c)
Premium
The Fly
Protara Therapeutics reports Q2 EPS (35c), consensus (38c)
1M ago
Protara appoints William Conkling as Chief Commercial Officer
PremiumThe FlyProtara appoints William Conkling as Chief Commercial Officer
4M ago
Protara Therapeutics initiated with a Buy at JonesResearch
Premium
The Fly
Protara Therapeutics initiated with a Buy at JonesResearch
4M ago
Protara Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Protara Therapeutics Reports Q1 2025 Financial Results
4M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
Protara Therapeutics’ TARA-002: Promising Phase 2 Results and Market Potential in NMIBC Treatment
Premium
Ratings
Protara Therapeutics’ TARA-002: Promising Phase 2 Results and Market Potential in NMIBC Treatment
5M ago
TARA Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
TARA Upcoming Earnings Report: What to Expect?
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100